BM

Brian Meltzer

Alterity Therapeutics Limited | Non-Executive Director
Mr Meltzer has spent 25 years in investment banking. His expertise includes major property transactions, corporate advisory, corporate finance, management buyouts, venture capital and large-scale syndications. He has held a number of Board and Board Advisory roles for private companies in the human resources, health and wellness, aged care, software, entertainment and finance sectors, including Director of a federal government licensed Innovation Investment Fund. In 2015 he acquired a corporate health division of an American multinational then grew it five-fold before selling it in 2021 to the subsidiary of a Canadian multinational.

Company and Role

Company
Title
Tenure
Since
ATH
Alterity Therapeutics Limited
  • Non-Executive Director
25yrs, 5mthDec 1999

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
ATH
Alterity Therapeutics Limited
24/04/259,415,584N/A40,138,528N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
ATH
Alterity Therapeutics Limited
24/04/25
Issued
757,576$0.008$6,060Issue of options
ATH
Alterity Therapeutics Limited
07/04/25
Buy
2,272,727$0.011$25,000Placement
ATH
Alterity Therapeutics Limited
30/12/24
Issued
30,000,000$0.008$240,000Employee Share Ownership Plan
ATH
Alterity Therapeutics Limited
08/01/24
Issued
7,142,857$0.003$24,999Placement
ATH
Alterity Therapeutics Limited
08/01/24
Issued
9,523,809$0.004$38,095Placement